Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengqian Chen

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Advanced Drug Delivery Reviews|May 9, 2022
Demystifying phytoconstituent-derived nanomedicines in their immunoregulatory and therapeutic roles in inflammatory diseasesFengqian Chen, Qi Liu
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|December 5, 2019
Strategies for nonviral nanoparticle-based delivery of CRISPR/Cas9 therapeuticsFengqian Chen, Martin Alphonse, Qi Liu
Antioxidants & Redox Signaling|February 16, 2021
Targeting Toll-Like Receptors in Sepsis: From Bench to Clinical TrialsFengqian Chen, Lin Zou, Brittney Williams, et al.
Frontiers in Oncology|November 1, 2021
Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in MicroenvironmentFengqian Chen, Jingquan Li, Hui Wang, et al.
Chemical Society Reviews|February 19, 2020
Design and applications of three dimensional covalent organic frameworksXinyu Guan, Fengqian Chen, Qianrong Fang, et al.
International Journal of Nanomedicine|June 30, 2021
Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel DiseaseFengqian Chen, Qi Liu, Yang Xiong, et al.
Angewandte Chemie (International Ed. in English)|October 17, 2022
Three-Dimensional Covalent Organic Frameworks: From Synthesis to ApplicationsXinyu Guan, Fengqian Chen, Shilun Qiu, et al.
Frontiers in Pharmacology|September 15, 2022
Nucleic acid strategies for infectious disease treatments: The nanoparticle-based oral delivery routeFengqian Chen, Qi Liu, Yang Xiong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 24, 2016
Glycyrrhetinic acid-decorated and reduction-sensitive micelles for targeted cancer therapyFengqian Chen, Jinming Zhang, Yitao Wang, et al.
Current Drug Targets|May 16, 2020
Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer TherapyFengqian Chen, Yunzhen Shi, Jinming Zhang, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Advanced Drug Delivery Reviews|May 9, 2022
Demystifying phytoconstituent-derived nanomedicines in their immunoregulatory and therapeutic roles in inflammatory diseasesFengqian Chen, Qi Liu
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|December 5, 2019
Strategies for nonviral nanoparticle-based delivery of CRISPR/Cas9 therapeuticsFengqian Chen, Martin Alphonse, Qi Liu
Antioxidants & Redox Signaling|February 16, 2021
Targeting Toll-Like Receptors in Sepsis: From Bench to Clinical TrialsFengqian Chen, Lin Zou, Brittney Williams, et al.
Frontiers in Oncology|November 1, 2021
Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in MicroenvironmentFengqian Chen, Jingquan Li, Hui Wang, et al.
Chemical Society Reviews|February 19, 2020
Design and applications of three dimensional covalent organic frameworksXinyu Guan, Fengqian Chen, Qianrong Fang, et al.
International Journal of Nanomedicine|June 30, 2021
Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel DiseaseFengqian Chen, Qi Liu, Yang Xiong, et al.
Angewandte Chemie (International Ed. in English)|October 17, 2022
Three-Dimensional Covalent Organic Frameworks: From Synthesis to ApplicationsXinyu Guan, Fengqian Chen, Shilun Qiu, et al.
Frontiers in Pharmacology|September 15, 2022
Nucleic acid strategies for infectious disease treatments: The nanoparticle-based oral delivery routeFengqian Chen, Qi Liu, Yang Xiong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 24, 2016
Glycyrrhetinic acid-decorated and reduction-sensitive micelles for targeted cancer therapyFengqian Chen, Jinming Zhang, Yitao Wang, et al.
Current Drug Targets|May 16, 2020
Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer TherapyFengqian Chen, Yunzhen Shi, Jinming Zhang, et al.
Pageof 5